“praluent” Archives

in
Entry Author Date Location
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Amgen Bests Sanofi-Regeneron In PCSK9 Patent Case, Losers Vow Appeal 03/16/16 New York
West Coast Biotech Roundup: Caribou, Amgen, CytomX, Arena & More 10/08/15 Boston
East Coast Biotech Roundup: StartUp Health, Constellation, Highline & More 08/28/15 New York
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
FDA OKs Cholesterol Fighter Praluent For More Patients Than Expected 07/24/15 New York
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors 07/07/15 Detroit Ann Arbor
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Rare Heart Disease Advocate: “I’m More Relieved Than I’ve Ever Been” 06/10/15 National
Advisors to FDA: Approve New Cholesterol Drug, But With Caveats 06/10/15 National
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
Page 2 of 2 « previous page